BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10714214)

  • 1. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
    Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H
    Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma.
    Brauch H; Weirich G; Hornauer MA; Störkel S; Wöhl T; Brüning T
    J Natl Cancer Inst; 1999 May; 91(10):854-61. PubMed ID: 10340905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal carcinogenicity of trichloroethylene: update, mode of action, and fundamentals for occupational standard setting.
    Harth V; Brüning T; Bolt HM
    Rev Environ Health; 2005; 20(2):103-18. PubMed ID: 16121833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.
    Jiang F; Desper R; Papadimitriou CH; Schäffer AA; Kallioniemi OP; Richter J; Schraml P; Sauter G; Mihatsch MJ; Moch H
    Cancer Res; 2000 Nov; 60(22):6503-9. PubMed ID: 11103820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
    Sanjmyatav J; Schubert J; Junker K
    Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
    Gnarra JR; Lerman MI; Zbar B; Linehan WM
    Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene.
    Brüning T; Weirich G; Hornauer MA; Höfler H; Brauch H
    Arch Toxicol; 1997; 71(5):332-5. PubMed ID: 9137812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of multifocal renal cell carcinoma by comparative genomic hybridization.
    Junker K; Hindermann W; Schubert J; Schlichter A
    Anticancer Res; 1999; 19(2C):1487-92. PubMed ID: 10365129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.
    Hoefling C; Schmidt H; Meinhardt M; Lohse A; Taubert H; Fuessel S; Schmidt U; Schuster K; Baretton G; Wirth MP; Meye A
    Int J Mol Med; 2004 Jun; 13(6):835-42. PubMed ID: 15138621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of lung metastases in renal cell carcinoma.
    Junker K; Sänger J; Schmidt A; Hindermann W; Presselt N; Helfritzsch H; Schubert J
    Oncol Rep; 2003; 10(4):1035-8. PubMed ID: 12792766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VHL mutations in renal cell cancer: does occupational exposure to trichloroethylene make a difference?
    Brauch H; Weirich G; Klein B; Rabstein S; Bolt HM; Brüning T
    Toxicol Lett; 2004 Jun; 151(1):301-10. PubMed ID: 15177666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma.
    Moch H; Presti JC; Sauter G; Buchholz N; Jordan P; Mihatsch MJ; Waldman FM
    Cancer Res; 1996 Jan; 56(1):27-30. PubMed ID: 8548768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.